CH641571A5 - Procede et reactifs pour la determination de l'hemoglobine glucosylee dans le sang. - Google Patents
Procede et reactifs pour la determination de l'hemoglobine glucosylee dans le sang. Download PDFInfo
- Publication number
- CH641571A5 CH641571A5 CH1142879A CH1142879A CH641571A5 CH 641571 A5 CH641571 A5 CH 641571A5 CH 1142879 A CH1142879 A CH 1142879A CH 1142879 A CH1142879 A CH 1142879A CH 641571 A5 CH641571 A5 CH 641571A5
- Authority
- CH
- Switzerland
- Prior art keywords
- hemoglobin
- allosteric
- glucosylated
- forms
- binding
- Prior art date
Links
- 108010054147 Hemoglobins Proteins 0.000 title claims description 73
- 102000001554 Hemoglobins Human genes 0.000 title claims description 73
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 31
- 210000004369 blood Anatomy 0.000 title claims description 19
- 239000008280 blood Substances 0.000 title claims description 19
- 238000000034 method Methods 0.000 title claims description 18
- 230000003281 allosteric effect Effects 0.000 claims description 30
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 23
- 229940068041 phytic acid Drugs 0.000 claims description 23
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 22
- 239000003446 ligand Substances 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 20
- 230000027455 binding Effects 0.000 claims description 18
- 108010061951 Methemoglobin Proteins 0.000 claims description 17
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 15
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 claims description 11
- 210000003743 erythrocyte Anatomy 0.000 claims description 11
- 230000009089 cytolysis Effects 0.000 claims description 8
- 239000003599 detergent Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- -1 potassium ferricyanide Chemical compound 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000006073 displacement reaction Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000007800 oxidant agent Substances 0.000 claims description 5
- 230000008856 allosteric binding Effects 0.000 claims description 4
- 230000001590 oxidative effect Effects 0.000 claims description 4
- 238000000862 absorption spectrum Methods 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 239000012637 allosteric effector Substances 0.000 claims 2
- 238000004587 chromatography analysis Methods 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 150000003278 haem Chemical group 0.000 claims 2
- 230000009257 reactivity Effects 0.000 claims 2
- 238000005481 NMR spectroscopy Methods 0.000 claims 1
- 238000004847 absorption spectroscopy Methods 0.000 claims 1
- 238000002983 circular dichroism Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 238000001962 electrophoresis Methods 0.000 claims 1
- 230000000704 physical effect Effects 0.000 claims 1
- 238000004611 spectroscopical analysis Methods 0.000 claims 1
- 230000007704 transition Effects 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 13
- 229920004890 Triton X-100 Polymers 0.000 description 6
- 239000013504 Triton X-100 Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 108010002255 deoxyhemoglobin Proteins 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- FSBLVBBRXSCOKU-UHFFFAOYSA-N n-butyl isocyanide Chemical compound CCCC[N+]#[C-] FSBLVBBRXSCOKU-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- XOHUEYCVLUUEJJ-UHFFFAOYSA-I 2,3-Diphosphoglycerate Chemical compound [O-]P(=O)([O-])OC(C(=O)[O-])COP([O-])([O-])=O XOHUEYCVLUUEJJ-UHFFFAOYSA-I 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- HYRHLJWTFKJITA-UHFFFAOYSA-N 3-hydroxy-2-(hydroxymethyl)propanamide Chemical compound NC(=O)C(CO)CO HYRHLJWTFKJITA-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 108010085682 Hemoglobin A Proteins 0.000 description 1
- 102000007513 Hemoglobin A Human genes 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CTPQAXVNYGZUAJ-UHFFFAOYSA-N Inositol pentaphosphate Natural products OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O CTPQAXVNYGZUAJ-UHFFFAOYSA-N 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- CTPQAXVNYGZUAJ-UYSNGIAKSA-N [(1s,2r,4s,5r)-3-hydroxy-2,4,5,6-tetraphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)C(OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O CTPQAXVNYGZUAJ-UYSNGIAKSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- RRUDCFGSUDOHDG-UHFFFAOYSA-N acetohydroxamic acid Chemical compound CC(O)=NO RRUDCFGSUDOHDG-UHFFFAOYSA-N 0.000 description 1
- 229960001171 acetohydroxamic acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000001913 cyanates Chemical class 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002527 isonitriles Chemical class 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- RCIBIGQXGCBBCT-UHFFFAOYSA-N phenyl isocyanide Chemical class [C-]#[N+]C1=CC=CC=C1 RCIBIGQXGCBBCT-UHFFFAOYSA-N 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 102220131337 rs886045804 Human genes 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- XBMGRDWEYMVTOS-UHFFFAOYSA-M sodium;2-iodobenzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1I XBMGRDWEYMVTOS-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/723—Glycosylated haemoglobin
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04M—TELEPHONIC COMMUNICATION
- H04M19/00—Current supply arrangements for telephone systems
- H04M19/02—Current supply arrangements for telephone systems providing ringing current or supervisory tones, e.g. dialling tone or busy tone
- H04M19/04—Current supply arrangements for telephone systems providing ringing current or supervisory tones, e.g. dialling tone or busy tone the ringing-current being generated at the substations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Signal Processing (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/973,368 US4200435A (en) | 1978-12-26 | 1978-12-26 | Determination of glycosylated hemoglobin in blood |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH641571A5 true CH641571A5 (fr) | 1984-02-29 |
Family
ID=25520823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1142879A CH641571A5 (fr) | 1978-12-26 | 1979-12-21 | Procede et reactifs pour la determination de l'hemoglobine glucosylee dans le sang. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4200435A (enExample) |
| JP (1) | JPS5587954A (enExample) |
| AT (1) | AT362534B (enExample) |
| AU (1) | AU528008B2 (enExample) |
| BE (1) | BE880817A (enExample) |
| CA (1) | CA1119081A (enExample) |
| CH (1) | CH641571A5 (enExample) |
| DE (1) | DE2950457B2 (enExample) |
| ES (1) | ES487265A0 (enExample) |
| FR (1) | FR2445527A1 (enExample) |
| GB (1) | GB2038476B (enExample) |
| IT (1) | IT1198318B (enExample) |
| NL (1) | NL7908272A (enExample) |
| SE (1) | SE445147B (enExample) |
| ZA (1) | ZA795808B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2850603A1 (de) * | 1978-11-22 | 1980-06-19 | Merck Patent Gmbh | Haemolysierloesung und verfahren zur haemolyse von blut |
| US4270921A (en) * | 1979-09-24 | 1981-06-02 | Graas Joseph E | Microchromatographic device and method for rapid determination of a desired substance |
| US4274978A (en) * | 1979-12-07 | 1981-06-23 | Abbott Laboratories | Standards for determining glycosylated hemoglobin |
| US4260516A (en) * | 1979-12-07 | 1981-04-07 | Abbott Laboratories | Glycosylated hemoglobin standards |
| CA1146769A (en) * | 1980-02-04 | 1983-05-24 | Beat E. Glatthaar | Process for the determination of diabetes |
| US4465774A (en) * | 1981-07-16 | 1984-08-14 | Sherwood Medical Company | Standard or control material for glysocylated or total hemoglobin determination |
| DE3141146A1 (de) * | 1981-10-16 | 1983-04-28 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und reagens zur bestimmung von glykosiliertem haemoglobin |
| NZ199380A (en) * | 1981-12-23 | 1986-08-08 | J R Baker | Determination of serum glucose levels in blood samples |
| US4629692A (en) * | 1982-12-06 | 1986-12-16 | Miles Laboratories, Inc. | Immunoassay for nonenzymatically glucosylated proteins and protein fragments an index of glycemia |
| US4876188A (en) * | 1986-11-18 | 1989-10-24 | Scripps Clinic And Research Foundation | Novel immunochemical method for assaying stable glycosylated hemoglobin |
| JPH0251091A (ja) * | 1988-08-12 | 1990-02-21 | Sharp Corp | スケジュール登録装置 |
| US5110745A (en) * | 1989-06-01 | 1992-05-05 | The Trustees Of The University Of Pennsylvania | Methods of detecting glycated proteins |
| US5807747A (en) * | 1989-06-13 | 1998-09-15 | Clinical Innovations Limited | Method and apparatus for determination of glycosylated protein |
| US5484735A (en) * | 1989-08-23 | 1996-01-16 | Northwestern University | Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated N-terminal amino acids |
| US5571723A (en) * | 1991-02-07 | 1996-11-05 | Evans; Cody A. | Method of testing for diabetes that reduces the effect of interfering substances |
| DE4206932A1 (de) * | 1992-03-05 | 1993-09-09 | Boehringer Mannheim Gmbh | Immunologische methode zur bestimmung eines haemoglobinderivates |
| DE69527947T2 (de) * | 1994-03-11 | 2003-05-28 | Abbott Laboratories, Abbott Park | Cyanidfreies reagens und verfahren zur bestimmung von hämoglobin |
| EP0770216A1 (en) * | 1994-07-14 | 1997-05-02 | Abbott Laboratories | Methods and reagents for cyanide-free determination of hemoglobin and leukocytes in whole blood |
| US5834315A (en) * | 1994-12-23 | 1998-11-10 | Coulter Corporation | Cyanide-free reagent and method for hemoglobin determination and leukocyte differentitation |
| JP4879441B2 (ja) * | 2000-05-23 | 2012-02-22 | 広司 早出 | 糖化蛋白質の測定キット |
| RU2186397C2 (ru) * | 2000-06-05 | 2002-07-27 | Волчков Алексей Борисович | Способ определения концентрации метгемоглобина в крови |
| US6844149B2 (en) * | 2001-06-29 | 2005-01-18 | International Business Machines Corporation | Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements |
| US7034126B2 (en) * | 2003-05-14 | 2006-04-25 | Agennix, Inc. | Lactoferrin in the treatment of diabetes mellitus |
| US7183381B2 (en) * | 2004-10-26 | 2007-02-27 | Agennix, Inc. | Composition of lactoferrin related peptides and uses thereof |
| ES2951329T3 (es) * | 2019-01-29 | 2023-10-19 | Siemens Healthcare Diagnostics Inc | Algoritmo de normalización de la turbidez y métodos para reducir la interferencia de intralípido/lipemia en los ensayos de hemoglobina A1c |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3918905A (en) * | 1973-07-20 | 1975-11-11 | Biolog Corp Of America | Diagnostic test for the determination of sickling hemoglobinopathies |
| US3958560A (en) * | 1974-11-25 | 1976-05-25 | Wayne Front March | Non-invasive automatic glucose sensor system |
| US3964865A (en) * | 1975-01-30 | 1976-06-22 | Sigma Chemical Company | Lyophilized human hemoglobin standard for colorimetric determination of total hemoglobin |
| US4077772A (en) * | 1977-05-31 | 1978-03-07 | Baxter Travenol Laboratories, Inc. | Method for the determination of hemoglobin in trace amounts |
| US4142858A (en) * | 1977-12-02 | 1979-03-06 | Isolab, Incorporated | Method to determine a diagnostic indicator of blood sugar condition, and, a liquid chromatographic microcolumn therefor |
-
1978
- 1978-12-26 US US05/973,368 patent/US4200435A/en not_active Expired - Lifetime
-
1979
- 1979-10-29 CA CA000338610A patent/CA1119081A/en not_active Expired
- 1979-10-30 ZA ZA00795808A patent/ZA795808B/xx unknown
- 1979-11-01 GB GB7937929A patent/GB2038476B/en not_active Expired
- 1979-11-12 NL NL7908272A patent/NL7908272A/nl not_active Application Discontinuation
- 1979-11-13 AU AU52754/79A patent/AU528008B2/en not_active Ceased
- 1979-12-14 SE SE7910340A patent/SE445147B/sv not_active IP Right Cessation
- 1979-12-14 DE DE2950457A patent/DE2950457B2/de not_active Ceased
- 1979-12-21 CH CH1142879A patent/CH641571A5/fr not_active IP Right Cessation
- 1979-12-21 IT IT28370/79A patent/IT1198318B/it active
- 1979-12-21 AT AT808579A patent/AT362534B/de not_active IP Right Cessation
- 1979-12-21 JP JP16581279A patent/JPS5587954A/ja active Granted
- 1979-12-21 BE BE0/198711A patent/BE880817A/fr not_active IP Right Cessation
- 1979-12-24 FR FR7931601A patent/FR2445527A1/fr active Granted
- 1979-12-26 ES ES487265A patent/ES487265A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2445527A1 (fr) | 1980-07-25 |
| JPS6363865B2 (enExample) | 1988-12-08 |
| GB2038476A (en) | 1980-07-23 |
| NL7908272A (nl) | 1980-06-30 |
| SE7910340L (sv) | 1980-06-27 |
| IT7928370A0 (it) | 1979-12-21 |
| ATA808579A (de) | 1980-10-15 |
| JPS5587954A (en) | 1980-07-03 |
| US4200435A (en) | 1980-04-29 |
| BE880817A (fr) | 1980-06-23 |
| FR2445527B1 (enExample) | 1983-09-02 |
| ES8103381A1 (es) | 1981-02-16 |
| AU5275479A (en) | 1980-07-03 |
| DE2950457B2 (de) | 1981-04-02 |
| CA1119081A (en) | 1982-03-02 |
| GB2038476B (en) | 1983-05-05 |
| IT1198318B (it) | 1988-12-21 |
| AU528008B2 (en) | 1983-03-31 |
| AT362534B (de) | 1981-05-25 |
| ZA795808B (en) | 1980-10-29 |
| SE445147B (sv) | 1986-06-02 |
| DE2950457A1 (de) | 1980-07-03 |
| ES487265A0 (es) | 1981-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH641571A5 (fr) | Procede et reactifs pour la determination de l'hemoglobine glucosylee dans le sang. | |
| US4255385A (en) | Reagent and test kit for determining glycosylated hemoglobin | |
| Smulevich et al. | Conformational change and histidine control of heme chemistry in cytochrome c peroxidase: resonance Raman evidence from Leu-52 and Gly-181 mutants of cytochrome c peroxidase | |
| Roth et al. | The quantitative determination of galactose—an enzymic method using galactose oxidase, with applications to blood and other biological fluids | |
| CN104105968B (zh) | 用于使用酶法对糖化血红蛋白进行定量分析的溶血试剂组合物 | |
| KR100601272B1 (ko) | 산화환원반응을 이용한 측정방법 | |
| Merzouk et al. | Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients | |
| BE1004336A3 (fr) | Procede de separation et de quantification de l'hemoglobine glycosylee hb a1c. | |
| CA1199257A (en) | Determination of glycosilated haemoglobin | |
| US4260516A (en) | Glycosylated hemoglobin standards | |
| Bohnenkamp et al. | Copper deficiency and erythrocuprein (2Cu, 2Zn-superoxide dismutase) | |
| Rajagopalan | Sulfite oxidase (sulfite: ferricytochrome c oxidoreductase) | |
| Ciriolo et al. | Transduction of reducing power across the plasma membrane by reduced glutathione: A 1H‐NMR spin‐echo study of intact human erythrocytes | |
| FR2471605A1 (fr) | Reactifs etalonnes pour la determination de l'hemoglobine glucosylee | |
| JP3598273B2 (ja) | ヘモグロビン妨害を排除しつつアルカリホスファターゼを測定する方法 | |
| Hayashi et al. | Heterogeneity of urinary albumin from diabetic patients | |
| Speisky et al. | Copper-binding proteins in human erythrocytes: Searching for potential biomarkers of copper over-exposure | |
| JP3181390B2 (ja) | タンパク質の糖化割合の測定方法 | |
| NZ331491A (en) | Process to eliminate haemoglobin errors when analysing medical samples using a main and a secondary measuring wavelength | |
| Kaftory et al. | Improved determination of cytochrome b5 in human erythrocytes. | |
| JPS63201567A (ja) | 生体試料中の還元物質の除去法 | |
| BE1000913A3 (fr) | Composition et procede pour determiner le taux de magnesium de liquides. | |
| FR2559267A1 (fr) | Procede pour la determination de la teneur en glucose de proteines glycosylees non-enzymatiquement et un kit de reactifs pour la realisation de ce procede | |
| JP2000023695A (ja) | 試料の処理方法 | |
| JPH0775559B2 (ja) | Ｇｏｔ又はｇｏｔアイソザイム活性測定におけるアポ酵素のホロ化の方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |